NCT06169202 2023-12-13
A Study of Fruquintinib in Combination With Irinotecan and Capecitabine for the Second-line Treatment of Patients
China Medical University, China
Unknown
Clinical Trials
11 trialsNCT06068023 2023-10-05
ADAPTA
Fondazione Poliambulanza Istituto Ospedaliero
Recruiting
NCT04915807 2021-06-07
Real-world Data (RWD) of Ramucirumab Plus Paclitaxel
Hallym University Medical Center
Unknown
NCT01039506 2019-05-29
An Observational Study of CPT-11 Based Regimens and UGT1A1 Genotypes in Metastatic Colorectal Cancer (mCRC)
Daiichi Sankyo
Completed
NCT01040312 2019-05-23
An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors
Daiichi Sankyo
Completed
NCT03923036 2019-04-22
AVOCETTE
University Hospital, Caen
Unknown
NCT03668418 2018-09-12
xenoZ
University of Pisa
Unknown
NCT03532711 2018-05-22
Potential Predictive Biomarkers in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal Cancer
Fudan University
Completed
NCT00003843 2015-02-16
Irinotecan in Treating Patients With Colorectal Cancer
California Cancer Consortium
Terminated
NCT01533740 2014-02-04
Circulating Regulatory Lymphocytes and Outcome of Metastatic Colorectal Cancer Patients
University of Rome Tor Vergata
Completed
NCT01311050 2011-12-13
A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer
King Faisal Specialist Hospital & Research Center
Unknown